Related Experiment Videos
Mutagenicity of psoralen epoxides
Mutation Research
|September 1, 1980
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU), a soluble epoxide hydrolase inhibitor, lowers L-NAME-induced hypertension through suppression of angiotensin-converting enzyme in rats.
European review for medical and pharmacological sciences·2020
Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption.
Journal of periodontal research·2018
Metabolic/inflammatory/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target.
Neuroscience and biobehavioral reviews·2018
Pharmacokinetics and antinociceptive effects of the soluble epoxide hydrolase inhibitor t-TUCB in horses with experimentally induced radiocarpal synovitis.
Journal of veterinary pharmacology and therapeutics·2017
miR-145-5p induces ferroptosis by targeting Notch2 to suppress melanoma progression.
Mutation research·2026
Melphalan-induced serpentine supravenous hyperpigmentation with associated venous thrombosis.
Oxford medical case reports·2026
Csf1-Csf1r expression and late circulating CSF1 elevation during P23H retinal degeneration.
Experimental and molecular pathology·2026
Coexistence of Acantholytic Dyskeratosis and Epidermolytic Hyperkeratosis in a Single Cutaneous Lesion: A Case Report and Brief Review.
The American Journal of dermatopathology·2026